Been diagnosed with NAION
According to clinical trial data from the STEP trials, 43.9% of patients taking semaglutide 2.4 mg experienced nausea at some point during treatment, with the majority of episodes occurring during or immediately after dose increases
however, they have important limitations in achieving sustainable long-term weight loss
Clinical Experience From members of the Microdose program
The lawyer might look for information about why the client started taking Ozempic, what dosage and frequency they were on, and when they began experiencing side effects
While this small case study doesnt provide strong scientific evidence that these drugs can also be used to treat alcohol use disorder, experts say it does reinforce the need for larger, randomized clinical trials that are in early stages